Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pieragostini

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annales Pharmaceutiques Francaises|September 24, 2021
[A check-list in order to optimise the deployment of computerized medicine cabinets in a hospital: An essential support]R Pieragostini, B Le Corre, V Poupon, et al.
Annales Pharmaceutiques Francaises|February 13, 2022
[Assessment of the impact of pharmaceutical consultations at initiation of a treatment with emicizumab in patients with severe hemophilia A without inhibitors]M Nasr Allah, R Pieragostini, G Oka, et al.
Annales Pharmaceutiques Francaises|November 14, 2022
[Assessment of the budgetary impact of an emicizumab therapy introduction for patients with severe haemophilia A without inhibitor]G Oka, R Pieragostini, V Roussel-Robert, et al.
Annales Pharmaceutiques Francaises|August 15, 2018
[Subcontracting a steam sterilization activity: Impact on surgical instruments]R Pieragostini, L Franconeri, G Branger, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annales Pharmaceutiques Francaises|September 24, 2021
[A check-list in order to optimise the deployment of computerized medicine cabinets in a hospital: An essential support]R Pieragostini, B Le Corre, V Poupon, et al.
Annales Pharmaceutiques Francaises|February 13, 2022
[Assessment of the impact of pharmaceutical consultations at initiation of a treatment with emicizumab in patients with severe hemophilia A without inhibitors]M Nasr Allah, R Pieragostini, G Oka, et al.
Annales Pharmaceutiques Francaises|November 14, 2022
[Assessment of the budgetary impact of an emicizumab therapy introduction for patients with severe haemophilia A without inhibitor]G Oka, R Pieragostini, V Roussel-Robert, et al.
Annales Pharmaceutiques Francaises|August 15, 2018
[Subcontracting a steam sterilization activity: Impact on surgical instruments]R Pieragostini, L Franconeri, G Branger, et al.
Pageof 1